Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 83.78 0.00%
MNPR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $562.35M
- EPS (TTM)
- -$2.20
- Dividend yield
- None
- 52-week range
- 50.07 – 124.82
- Day range
- 78.00 – 85.03
- Volume / Avg
- 107.03K / 218.50K
- Beta
- —
- Shares outstanding
- 6.71M
52-week range
MNPR stock today
Monopar Therapeutics (MNPR) closed at $83.78 on Oct 7, up 5.29% (+$4.21), versus the S&P 500's 0.22% decline. Trading was light, with 107.03K shares changing hands, about 49% of the average daily volume. Shares are 32.9% below their 52-week high of $124.82, set on Aug 6, 2026 and 67.3% above the 52-week low of $50.07, in the middle of the past year's range.
MNPR is up 28.3% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 15.0%. Monopar Therapeutics has posted a net loss over the last twelve months (EPS of -$2.20), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Monopar Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Monopar Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs MNPR |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs MNPR |
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs MNPR |
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs MNPR |
| ALTAltimmune Inc. | 2.66 | -0.37% | $517.42M | vs MNPR |
| PHATPhathom Pharmaceuticals Inc. | 6.81 | +0.44% | $550.94M | vs MNPR |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs MNPR |
| CTMXCytomX Therapeutics Inc. | 2.55 | -0.39% | $555.64M | vs MNPR |
Indexes, lists and sector
Monopar Therapeutics stock FAQ
What is Monopar Therapeutics's stock price today?
MNPR last traded at $83.78 as of Oct 7, 4:00 PM EDT, up 5.29% on the day. Prices are delayed at least 15 minutes.
Does Monopar Therapeutics pay a dividend?
No. Monopar Therapeutics does not currently pay a regular cash dividend.
Has MNPR ever split its stock?
Yes. The most recent MNPR stock split was a 1-for-5 split on Aug 13, 2024.
What is the MNPR 52-week high?
The 52-week high for MNPR is $124.82 and the 52-week low is $50.07. The stock is currently 32.9% below its high.